Prot #PRT3789-01: A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT3789 as Monotherapy and in Combination with Docetaxel in Participants with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation

Project: Research project

Project Details

StatusActive
Effective start/end date1/10/251/10/28

Funding

  • PPD Investigator Services, LLC (Prot #PRT3789-01 // Prot #PRT3789-01)
  • Prelude Therapeutics Inc (Prot #PRT3789-01 // Prot #PRT3789-01)